Biotech Biogen Receives Positive CHMP Opinion for TOFIDENCEBy AndyApril 30, 2024 Biogen Receives Positive CHMP Opinion for TOFIDENCE (tocilizumab), a Biosimilar Referencing ROACTEMRA Biogen Inc. (Nasdaq: BIIB) has announced that the…
Biotech Voydeya Approved as Add-On Therapy for PNH in USBy AndyApril 5, 2024 Voydeya approved in the US as add-on therapy to ravulizumab or eculizumab for treatment of extravascular haemolysis in adults with…
